SCHEMBL3115741

SCHEMBL3115741

CCCCn1c(=O)[nH]c(=O)c2[nH]c(Cc3ccccc3)nc21

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 5/20 0.58
ADORA2B P29275 5/20 0.58
PDE4A P27815 1/20 0.53
PDE4B Q07343 1/20 0.53
PDE4C Q08493 1/20 0.53
PDE4D Q08499 1/20 0.53
ALDH1A1 P00352 4/20 0.53
KDM4E B2RXH2 3/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
MEN1 O00255 1/20 0.53
HTT P42858 1/20 0.53
KMT2A Q03164 1/20 0.53
PCK1 P35558 2/20 0.52
HPGD P15428 1/20 0.51
TNF P01375 1/20 0.47
NOD2 Q9HC29 1/20 0.47
GLA P06280 1/20 0.47
GAA P10253 1/20 0.47
ATM Q13315 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3986626 0.84 PCK1 (0.63) ADORA2AADORA2BPDE4APDE4BPDE4C
SCHEMBL4626790 0.83 ADORA2A (0.58) ADORA2AADORA2BPDE4APDE4BPDE4C
SCHEMBL3848060 0.82 ADORA2A (0.57) ADORA2AADORA2BPDE4APDE4BPDE4C
SCHEMBL3110928 0.81 PNP (0.48) ADORA2AADORA2BALDH1A1KDM4ESMN1; SMN2
SCHEMBL19066311 0.81 ADORA2A (0.56) ADORA2AADORA2BPDE4APDE4BPDE4C
SCHEMBL14796914 0.81 ADORA2A (0.56) ADORA2AADORA2BPDE4APDE4BPDE4C
SCHEMBL9644450 0.79 ADORA2A (0.53) ADORA2AADORA2BPDE4APDE4BPDE4C
SCHEMBL190990 0.79 ADORA2A (0.59) ADORA2AADORA2BPDE4APDE4BPDE4C
SCHEMBL5033085 0.78 ADORA2B (0.62) ADORA2AADORA2BPCK1
SCHEMBL3980633 0.77 PCK1 (0.78) ADORA2AADORA2BPCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2146996-A1 XANTHINE COMPOUNDS HAVING A POSITIVE ALLOSTERIC GABAB RECEPTOR MODULATOR EFFECT AstraZeneca AB (SE) 2010-01-27 EP disclosed
WO-2008130314-A1 XANTHINE COMPOUNDS HAVING A POSITIVE ALLOSTERIC GABAB RECEPTOR MODULATOR EFFECT ASTRAZENECA AB (SE) 2008-10-30 WO disclosed